Impact of Renal Insufficiency on Prognosis of Patients with Acute Coronary Syndrome

References

• Piepoli MF, Hoes AW, Brotons C, Hobbs RFD, Corra U. Task Force for the 2016 guidelines on cardiovascular disease prevention in clinical practice. Main messages for primary care from the 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Eur J Gen Pract. 2018;24(1):51–56. doi:10.1080/13814788.2017.1398320
   PubMed Web of Science ®Google Scholar
• Virani SS, Alonso A, Aparicio HJ, et al. Heart disease and stroke statistics-2021 update: a report from the American Heart Association. Circulation. 2021;143(8):e254–e743. doi:10.1161/CIR.0000000000000950
   PubMed Web of Science ®Google Scholar
• Petersen JK, Butt JH, Yafasova A, et al. Incidence of ischaemic stroke and mortality in patients with acute coronary syndrome and first-time detected atrial fibrillation: a nationwide study. Eur Heart J. 2021:ehab575. doi:10.1093/eurheartj/ehab575
   Web of Science ®Google Scholar
• Committee of the Report on Cardiovascular Health and Diseases in China. Report on cardiovascular health and diseases burden in China: an updated summary of 2020. Chin Circ J. 2021;36(6):521–545.
   Google Scholar
• Bikbov B, Purcell CA, Levey AS; GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709–733. doi:10.1016/S0140-6736(20)30045-3
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379(9818):815–822. doi:10.1016/S0140-6736(12)60033-6
   PubMed Web of Science ®Google Scholar
• Pilmore HL, Xiong F, Choi Y, et al. Impact of chronic kidney disease on mortality and cardiovascular outcomes after acute coronary syndrome: a nationwide data linkage study (ANZACS-QI 44). Nephrology. 2020;25(7):535–543. doi:10.1111/nep.13703
   PubMed Web of Science ®Google Scholar
• Rott D, Klempfner R, Goldenberg I, Matetzky S, Elis A. Temporal trends in the outcomes of patients with acute myocardial infarction associated with renal dysfunction over the past decade. Eur J Intern Med. 2016;29:88–92. doi:10.1016/j.ejim.2015.12.020
   PubMed Web of Science ®Google Scholar
• Dohi T, Kasai T, Miyauchi K, et al. Prognostic impact of chronic kidney disease on 10-year clinical outcomes among patients with acute coronary syndrome. J Cardiol. 2012;60(6):438–442. doi:10.1016/j.jjcc.2012.08.007
   PubMed Web of Science ®Google Scholar
• Melloni C, Cornel JH, Hafley G, et al. Impact of chronic kidney disease on long-term ischemic and bleeding outcomes in medically managed patients with acute coronary syndromes: insights from the TRILOGY ACS Trial. Eur Heart J Acute Cardiovasc Care. 2016;5(6):443–454. doi:10.1177/2048872615598631
   PubMed Web of Science ®Google Scholar
• Sarnak MJ, Amann K, Bangalore S, et al. Chronic kidney disease and coronary artery disease: JACC state-of-the-art review. J Am Coll Cardiol. 2019;74(14):1823–1838. doi:10.1016/j.jacc.2019.08.1017
   PubMed Web of Science ®Google Scholar
• Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol. 1998;9(12 Suppl):S16–23.
   PubMedGoogle Scholar
• Collet JP, Thiele H, Barbato E, et al. 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42(14):1289–1367. doi:10.1093/eurheartj/ehaa575
   PubMed Web of Science ®Google Scholar
• Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Eur Heart J. 2012;33(20):2551–2567. doi:10.1093/eurheartj/ehs184
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. doi:10.7326/0003-4819-150-9-200905050-00006
   PubMed Web of Science ®Google Scholar
• Medi C, Montalescot G, Budaj A, et al. Reperfusion in patients with renal dysfunction after presentation with ST-segment elevation or left bundle branch block: GRACE (Global Registry of Acute Coronary Events). JACC Cardiovasc Interv. 2009;2(1):26–33. doi:10.1016/j.jcin.2008.09.010
   PubMed Web of Science ®Google Scholar
• Saltzman AJ, Stone GW, Claessen BE, et al. Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: the HORIZONS-AMI (Harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial. JACC Cardiovasc Interv. 2011;4(9):1011–1019. doi:10.1016/j.jcin.2011.06.012
   PubMed Web of Science ®Google Scholar
• Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American heart association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Hypertension. 2003;42(5):1050–1065. doi:10.1161/01.HYP.0000102971.85504.7c
   PubMed Web of Science ®Google Scholar
• McCullough Peter A. Cardiorenal risk: an important clinical intersection. Rev Cardiovasc Med. 2002;3(2):71–76.
   PubMedGoogle Scholar
• Cai Q, Mukku VK, Ahmad M. Coronary artery disease in patients with chronic kidney disease: a clinical update. Curr Cardiol Rev. 2013;9(4):331–339. doi:10.2174/1573403X10666140214122234
   PubMedGoogle Scholar
• Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol. 2008;52(19):1527–1539. doi:10.1016/j.jacc.2008.07.051
   PubMed Web of Science ®Google Scholar
• Papayianni A, Alexopoulos E, Giamalis P, et al. Circulating levels of ICAM-1, VCAM-1, and MCP-1 are increased in haemodialysis patients: association with inflammation, dyslipidaemia, and vascular events. Nephrol Dial Transplant. 2002;17(3):435–441. doi:10.1093/ndt/17.3.435
   PubMed Web of Science ®Google Scholar
• Baigent C, Landray MJ, Reith C, et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of heart and renal protection): a randomised placebo-controlled trial. Lancet. 2011;377(9784):2181–2192. doi:10.1016/S0140-6736(11)60739-3
   PubMed Web of Science ®Google Scholar
• Chertow GM, Normand SL, McNeil BJ. “Renalism”: inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency. J Am Soc Nephrol. 2004;15(9):2462–2468. doi:10.1097/01.ASN.0000135969.33773.0B
   PubMed Web of Science ®Google Scholar
• Wright RS, Reeder GS, Herzog CA, et al. Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med. 2002;137(7):563–570. doi:10.7326/0003-4819-137-7-200210010-00007
   PubMed Web of Science ®Google Scholar
• Levin A, Tonelli M, Bonventre J, et al. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. Lancet. 2017;390(10105):1888–1917. doi:10.1016/S0140-6736(17)30788-2
   PubMed Web of Science ®Google Scholar
• Bagai A, Lu D, Lucas J, et al. Temporal trends in utilization of cardiac therapies and outcomes for myocardial infarction by degree of chronic kidney disease: a report from the NCDR chest pain-MI registry. J Am Heart Assoc. 2018;7(24):e010394. doi:10.1161/JAHA.118.010394
   PubMed Web of Science ®Google Scholar
• Widimsky P, Rychlik I. Renal disease and acute coronary syndrome. Heart. 2010;96(1):86–92. doi:10.1136/hrt.2008.161034
   PubMed Web of Science ®Google Scholar
• Marenzi G, Lauri G, Assanelli E, et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 2004;44(9):1780–1785. doi:10.1016/j.jacc.2004.07.043
   PubMed Web of Science ®Google Scholar
• Kowalczyk J, Lenarczyk R, Kowalski O, et al. Different types of renal dysfunction in patients with acute myocardial infarction treated with percutaneous coronary intervention. J Interv Cardiol. 2007;20(2):143–152. doi:10.1111/j.1540-8183.2007.00253.x
   PubMedGoogle Scholar
• Margolis G, Vig S, Flint N, et al. Prognostic implications of chronic kidney disease on patients presenting with ST-segment elevation myocardial infarction with versus without stent thrombosis. Cardiorenal Med. 2017;7(2):150–157. doi:10.1159/000455905
   PubMed Web of Science ®Google Scholar
• Du X, Patel A, Anderson CS, et al. Epidemiology of cardiovascular disease in china and opportunities for improvement: JACC international. J Am Coll Cardiol. 2019;73(24):3135–3147. doi:10.1016/j.jacc.2019.04.036
   PubMed Web of Science ®Google Scholar
• Atkins ER, Du X, Wu Y, et al. Use of cardiovascular prevention treatments after acute coronary syndrome in China and associated factors. Int J Cardiol. 2017;241:444–449. doi:10.1016/j.ijcard.2017.03.057
   PubMed Web of Science ®Google Scholar
• Szummer K, Lundman P, Jacobson SH, et al. Influence of renal function on the effects of early revascularization in non-ST-elevation myocardial infarction: data from the Swedish Web-System for Enhancement and Development of Evidence-based care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART). Circulation. 2009;120(10):851–858. doi:10.1161/CIRCULATIONAHA.108.838169
   PubMed Web of Science ®Google Scholar
• Smith SC Jr, Benjamin EJ, Bonow RO, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association. J Am Coll Cardiol. 2011;58(23):2432–2446. doi:10.1016/j.jacc.2011.10.824
   PubMed Web of Science ®Google Scholar
• Piepoli MF, Hoes AW, Agewall S, et al. 2016 European guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315–2381. doi:10.1093/eurheartj/ehw106
   PubMed Web of Science ®Google Scholar
• Cheung AK, Chang TI, Cushman WC, et al. Executive summary of the KDIGO 2021 Clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int. 2021;99(3):559–569. doi:10.1016/j.kint.2020.10.026
   PubMed Web of Science ®Google Scholar
• Peng Y, Du X, Li X, et al. Association of renal insufficiency with treatments and outcomes in patients with acute coronary syndrome in China. Int J Cardiol. 2021;323:7–12. doi:10.1016/j.ijcard.2020.08.022
   PubMed Web of Science ®Google Scholar